Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Aliment Pharmacol Ther. 2020 Aug 8;52(6):976–987. doi: 10.1111/apt.16013

TABLE 3.

Linear discriminant analysis (LDA) effect size (LEfSe) in samples collected after treatment (Week 6)

Bacterial taxa Comparison of aspirin to placebo arm, Week 6
Class LDA P-value
Clostridium XIVa Aspirina 3.66 0.035
Clostridium XVIII Placeboa 3.49 0.005
Prevotella Aspirin 3.38 0.004
Veillonella Placebo 3.41 0.047
a

Class “Aspirin” means that the bacterium was more prevalent in the aspirin arm, and class. “Placebo” means that bacterium was more prevalent in the placebo arm.